Institutional investors interested in meeting with management during the conference may reach out to their J.P. Morgan representatives. About Solid Biosciences Solid Biosciences is a precision genetic ...
Solid Biosciences advances gene therapies for muscular and cardiac diseases, gaining FDA clearance for SGT-212 and targeting ...
On Jan. 18, hockey fans can attend the Wolverines game at 7 p.m. at JDA Place, and if they dress as superheroes, the adults get in for only $5. Those dollars are donated to this year’s charities, ...
Columnist Shalom Lim saw elements of his own journey with DMD reflected in the Netflix documentary "The Remarkable Life of ...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...
Joon Lee, an analyst from Truist Financial, has initiated a new Buy rating on Solid Biosciences (SLDB).Stay Ahead of the Market:Discover ...
Truist analyst Joon Lee initiated coverage of Solid Biosciences (SLDB) with a Buy rating and $16 price target Solid Biosciences, a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback